Chemical Component Summary

NameN,1,4,4-TETRAMETHYL-8-{[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE
IdentifiersN,1,4,4-tetramethyl-8-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-5H-pyrazolo[4,5-h]quinazoline-3-carboxamide
FormulaC25 H32 N8 O
Molecular Weight460.575
TypeNON-POLYMER
Isomeric SMILESCC1(Cc2cnc(nc2-c3c1c(nn3C)C(=O)NC)Nc4ccc(cc4)N5CCN(CC5)C)C
InChIInChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)
InChIKeyRXZMYLDMFYNEIM-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count66
Chiral Atom Count0
Bond Count70
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB16232 
NameMilciclib Maleate
Groups investigational
DescriptionMilciclib Maleate is under investigation in clinical trial NCT01301391 (Study of Oral PHA-848125AC in Patients With Malignant Thymoma Previously Treated With Multiple Lines of Chemotherapy).
Synonyms
  • Milciclib Maleate
  • Milciclib
CategoriesHeterocyclic Compounds, Fused-Ring
CAS number802539-81-7

Related Resource References

Resource NameReference
Pharos CHEMBL564829
PubChem 16718576
ChEMBL CHEMBL564829